Israeli firm gets U.S. nod for advanced trials for non-opiate painkiller


JERUSALEM (Reuters) – Israeli pharmaceuticals company PainReform has received approval from the U.S. Food and Drug Administration (FDA) to begin late-stage clinical studies for a pain relief drug that is a departure from opiate-based narcotics, it said on Tuesday.

FILE PHOTO: A pharmacists holds prescription painkiller Oxycodone Hydrochloride, 30mg pills, made by Mallinckrodt at a local pharmacy, in Provo, Utah, U.S., April 25, 2017. REUTERS/George Frey/File Photo

Many patients today dealing with pain after surgery are prescribed opioids, which can be highly addictive and are at the heart…



Read More Here

Be the first to comment on "Israeli firm gets U.S. nod for advanced trials for non-opiate painkiller"

Leave a comment

Your email address will not be published.


*